{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:32:43Z","timestamp":1789446763562,"version":"build-2803163510"},"reference-count":35,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Biopreservation and Biobanking"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>Global measures and restrictions implemented to control the COVID-19 pandemic had a significant impact and created challenges in regular business, commerce, and scientific activities, including biobank operations. The challenges were exacerbated by a dependence on imported supplies and reagents from countries such as the United States, China, and within Europe, as well as restrictions on exporting biological samples. The pandemic has highlighted the pressing need for regional autonomy in biobanking activities. This article aims to enhance the capacity of biobanks to respond effectively to future crises. Recognizing the importance of adaptability and resilience, our study highlights the specific strategies employed by a large biobank in Costa Rica to ensure the continuity of operations during unprecedented times. During the COVID-19 pandemic, biobanking operations encountered a number of critical challenges, which led to the identification, implementation, and integration of targeted mitigation strategies into our contingency framework. Five challenges were identified and subsequently addressed: disruptions and shortfalls in the supply of essential material, continuity of daily biobank operations, storage capacity constraints coupled with export limitations, difficulties associated with consent procedures, and complications surrounding personnel testing. These lessons underscore the critical importance of contingency planning, digitization of biobanking workflows, and increased regional collaboration to strengthen the autonomy and resilience of biobanks in the face of future crises.<\/jats:p>","DOI":"10.1177\/19475535251369966","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:57:35Z","timestamp":1758920255000},"page":"542-550","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Resilience of Biobanks in Latin America During the COVID-19 Pandemic: Lessons from Costa Rica"],"prefix":"10.1177","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8479-4965","authenticated-orcid":false,"given":"Michael","family":"Zu\u00f1iga","sequence":"first","affiliation":[{"name":"OncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California, USA."},{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Mora","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernal","family":"Cortes","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Loria","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amada","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Caja Costarricense del Seguro Social, San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Calderon","sequence":"additional","affiliation":[{"name":"Caja Costarricense del Seguro Social, San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ugalde-Araya","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Sargsyan","sequence":"additional","affiliation":[{"name":"OncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California, USA."},{"name":"International Biobanking and Education, Medical University of Graz, Graz, Austria."},{"name":"Department of Digital Medicine and Artificial Intelligence, Yerevan State Medical University, Yerevan, Armenia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Porras","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), Fundaci\u00f3n Inciensa (FUNIN), San Jos\u00e9, Costa Rica."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-6682","authenticated-orcid":false,"given":"Denis","family":"Marino","sequence":"additional","affiliation":[{"name":"OncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2020.0079"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/su13116314"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1109\/EMR.2020.3018420"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2020.29069.jjv"},{"key":"e_1_3_4_6_2","unstructured":"Mathieu E Ritchie H Rod\u00e9s-Guirao L et al. Costa Rica: Coronavirus Pandemic Country Profile. September 1 2024. Available from: https:\/\/ourworldindata.org\/coronavirus\/country\/costa-rica#citation [Last accessed: August29 2024]."},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2023.100616"},{"key":"e_1_3_4_8_2","unstructured":"Ministerio de Salud de Costa Rica. Lineamientos Nacionales para la vigilancia de la infecci\u00f3n por Coronavirus (2019-nCoV). 2024. Available from: https:\/\/www.ministeriodesalud.go.cr\/index.php\/vigilancia-de-la-salud\/41-lineamientos-coronavirus\/134-lineamientos-nacionales-para-la-vigilancia-de-la-infeccion-por-coronavirus-2019-ncov [Last accessed: August29 2024]."},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2022.23"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0066"},{"key":"e_1_3_4_11_2","unstructured":"Agencia Costarricense de Investigaciones Biom\u00e9dicas \u2013 Fundaci\u00f3n Inciensa (ACIB-FUNIN). Quienes Somos. Available from: https:\/\/acibfunin.com\/quienes-somos\/ [Last accessed: September1 2024]."},{"key":"e_1_3_4_12_2","unstructured":"Zuniga M. Un biobanco en Costa Rica: Una gu\u00eda general sobre el funcionamiento (Sesi\u00f3n de Congreso). Taller Internacional de Biobancos Humanos y Bases de Datos de Investigaci\u00f3n Gen\u00e9tica: Retos y Oportunidades para la Creaci\u00f3n de un Biobanco en Costa Rica. June 21 2023. Available from: https:\/\/www.youtube.com\/watch?v=GW_1RtDTK6w [Last accessed: September1 2024]."},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.11.041"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-071284"},{"key":"e_1_3_4_15_2","unstructured":"Cordero M. Validacion de pruebas de saliva contin\u00faa avanzando pese a negativa de la Caja. Available from: https:\/\/semanariouniversidad.com\/pais\/validacion-de-pruebas-de-saliva-continua-avanzando-pese-a-negativa-de-la-caja\/ June 8 2021 [Last accessed: October14 2024]."},{"key":"e_1_3_4_16_2","unstructured":"Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica TPET (PRISMA). Clinicaltrials.gov ID NCT05237947. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05237947 [Last accessed: November9 2024]."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2020.29074.mkh"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2020.0082"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2020.0083"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1256601"},{"key":"e_1_3_4_21_2","first-page":"156","article-title":"Hero and villain: The defense production act in the era of COVID-19","volume":"51","author":"Coto AF","year":"2022","unstructured":"Coto AF. Hero and villain: The defense production act in the era of COVID-19. Southwestern Law Review, 2022; 51:156\u2013173.","journal-title":"Southwestern Law Review"},{"key":"e_1_3_4_22_2","unstructured":"Benton M Batalova J Davidoff-Gore S Schmidt T. COVID-19 and the State of Global Mobility in 2020. April 2021. Available from: https:\/\/publications.iom.int\/system\/files\/pdf\/covid-19-and-the-state-of-global.pdf [Last accessed: December12 2024]."},{"key":"e_1_3_4_23_2","unstructured":"International Society for Biological and Environmental Repositories. Best Practices: Recommendation for Repositories. ISBER. 5th ed.; 2023. Available from: https:\/\/cdn.ymaws.com\/www.isber.org\/resource\/resmgr\/best_practices\/isberbestpracticeseng-5thedi.pdf [Last accessed: December12 2024]."},{"key":"e_1_3_4_24_2","unstructured":"MVE. MVE 1536 Dry Shipper. 2024. Available from: https:\/\/mvebio.com\/wp-content\/uploads\/sites\/4\/2024\/02\/MVE-1536-Dry-Shipper-Spec-Sheet.pdf [Last accessed: October19 2024]."},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2020-106858"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2021.401"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89242-z"},{"key":"e_1_3_4_28_2","unstructured":"Republica de Costa Rica. Ley Reguladora de Investigaci\u00f3n Biom\u00e9dica N\u00b0 9234. 2014. Available from: http:\/\/www.pgrweb.go.cr\/scij\/Busqueda\/Normativa\/Normas\/nrm_texto_completo.aspx?param1=NRTC&nValor1=1&nValor2=77070&nValor3=96424&strTipM=TC [Last accessed: December14 2024]."},{"key":"e_1_3_4_29_2","unstructured":"Republica de Costa Rica. Reglamento a La Ley Reguladora de Investigaci\u00f3n Biom\u00e9dica No 39061-S. 2023. Available from: http:\/\/www.pgrweb.go.cr\/scij\/Busqueda\/Normativa\/Normas\/nrm_texto_completo.aspx?param1=NRTC&nValor1=1&nValor2=79779&nValor3=101025&strTipM=TC [Last accessed: December14 2024]."},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2014.0045"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI200325"},{"key":"e_1_3_4_32_2","unstructured":"CEPAL. Las restricciones a la exportaci\u00f3n de productos m\u00e9dicos dificultan los esfuerzos por contener la enfermedad por coronavirus (COVID-19) en Am\u00e9rica Latina y el Caribe. May 2020. Available from: https:\/\/repositorio.cepal.org\/server\/api\/core\/bitstreams\/002d7034-8695-477f-9158-b6f71c340cc4\/content [Last accessed: October9 2024]."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104821"},{"key":"e_1_3_4_34_2","first-page":"2017","article-title":"General Requirements for the Competence of Testing and Calibration Laboratories","volume":"17025","author":"International Organization for Standardization","year":"2017","unstructured":"International Organization for Standardization. General Requirements for the Competence of Testing and Calibration Laboratories. 4th ed. ISO, 2017; 17025:2017. Available from: https:\/\/www.iso.org\/standard\/66912.html","journal-title":"ISO"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa149"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00776-20"}],"container-title":["Biopreservation and Biobanking"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19475535251369966","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19475535251369966","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19475535251369966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:23:25Z","timestamp":1787149405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19475535251369966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12,1]]}},"alternative-id":["10.1177\/19475535251369966"],"URL":"https:\/\/doi.org\/10.1177\/19475535251369966","relation":{},"ISSN":["1947-5535","1947-5543"],"issn-type":[{"value":"1947-5535","type":"print"},{"value":"1947-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}